- 4-Week Delivery: World’s fastest custom mouse model development.
- TurboMice™ Tech: Proprietary high-efficiency gene-editing platform.
- Full Capabilities: Expert conditional knockouts, knock-ins, and humanized models.
- Validated Quality: Guaranteed high precision and model viability.
Ogdh Flox Mouse Model
| Strain Name | Ogdh Flox Mouse Model (M30015) |
|---|---|
| Editing Type | Conditional knockout (floxed) |
| Gene Name | Ogdh (oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide); protein: 2-oxoglutarate dehydrogenase complex component E1 / E1o / α-KGDH-E1; EC 1.2.4.2; human ortholog OGDH) |
| Gene Synonyms | E1o; OGDH-E1; d1401; mKIAA4192; 2210403E04Rik; 2210412K19Rik |
| Strain Background | C57BL/6N |

- Cell-type-specific OGDH loss — Cross to any tissue- or cell-specific Cre driver (neurons, hepatocytes, tumor cells, cardiomyocytes) to delete the E1 subunit of the α-ketoglutarate dehydrogenase complex and read out the metabolic and functional consequences of a broken TCA cycle node.
- Cancer metabolism — Test how OGDH inactivation reshapes TCA flux, drives α-ketoglutarate accumulation, and affects tumor growth; evaluate TCA-cycle- and glutamine-directed therapeutic strategies.
- Neurodegeneration & neurodevelopment — Study neuronal and glial OGDH loss in relation to excitotoxicity, oxidative stress, and neurodegenerative disease; the enzyme is a documented site of mitochondrial ROS production and shows region-selective vulnerability under thiamine deficiency.
- Cardiac & renal metabolism — Exploit the highest endogenous expression in adult heart and kidney to model high-energy-tissue metabolic failure and oncometabolite (D-2-hydroxyglutarate) impairment of mitochondrial function.
- Rare metabolic disease modeling — Human OGDH is NCBI-annotated as implicated in oxoglutarate dehydrogenase deficiency, providing a direct ortholog basis for α-KGDH deficiency models.
This strain carries LoxP sites flanking critical exon(s) of the Ogdh gene, which encodes the E1 component (E1o) of the 2-oxoglutarate dehydrogenase complex—the thiamine pyrophosphate-dependent enzyme that oxidatively decarboxylates α-ketoglutarate to succinyl-CoA in the TCA cycle. The floxed allele is phenotypically normal on its own; Cre-mediated excision removes OGDH activity in a chosen cell type or tissue, letting the metabolic consequences of losing this TCA node be studied without the developmental burden of a whole-body deletion. OGDH sits at the intersection of energy production, α-ketoglutarate pool size, and mitochondrial redox chemistry, and has additionally been reported to associate with H2A.Z-occupied promoters and contribute to histone modification.
- Conditional by design — LoxP-flanked critical exon(s) allow deletion in any Cre-expressing compartment, which is the practical route for a TCA-cycle E1 subunit whose whole-body loss is expected to be developmentally severe.
- Directly assayed enzymology — GO annotates oxoglutarate dehydrogenase (succinyl-transferring) activity and membership of the oxoglutarate dehydrogenase complex by direct assay (IDA), with mitochondrial matrix localization confirmed the same way.
- High-energy tissue reach — Broad expression across 24 tissues, highest in adult heart (RPKM 260.2) and adult kidney (89.4), so cardiac and renal metabolic studies need no separate strain.
- Brain-region resolved — GO records cerebellar cortex, hippocampus, thalamus, striatum, pyramidal neuron and olfactory bulb mitral cell layer development plus tangential migration, all by expression pattern; postnatal brain shows high Ogdh mRNA in olfactory bulb, hippocampus, cerebellum and pons.
- Human rare-disease ortholog — Human OGDH is annotated by NCBI as implicated in oxoglutarate dehydrogenase deficiency; 76 PubMed citations support mechanistic and translational work.

FAQ
Game-changing benefits?
While competitors highlight germline efficiency gains, shorter timelines and enhanced 3Rs animal welfare benefits for their technologies, these are merely incremental improvements over traditional approaches. In sharp contrast, our proprietary technology delivers fully pure, homogeneous lineages—every single cell of the mice is derived exclusively from totipotent ES cells, with guaranteed 100% germline transmission efficiency. To experience these unparalleled benefits firsthand, enquire about your custom mouse model project with us or order embryos for in-house validation at your facility.
How much for a project assessment?
•Free initial design proposal with zero obligations.
•Request a free quote!
Who owns the mouse lP? Do l need a licence from Mingceler?
All model generation projects of Mingceler operate under a fee-for-service framework.
IP Ownership: All intellectual property rights related to custom mouse models, including derived organs, tissues, cells, and biological materials, are the sole and exclusive property of the Client.
Third-Party Transfer Permission: The Client may independently decide to retain, utilize, or commercialize their custom models project materials (e.g., targeting vectors, ES cells, mouse lines) without the need for prior consent from Mingceler.
Licensing Exemption: The Client has full autonomy over all uses of the custom models or their derivatives, including but not limited to commercialization, distribution to third parties, and publication involving model data. No written license from Mingceler is required for such uses.
